Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease

Bone Marrow Transplantation

Volumn 29, Issue 8, 2002, Pages 709-710

  Pusic, I ^a   Pavletic, S Z ^a   Kessinger, A ^a   Tarantolo, S R ^a   Bishop, M R ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AML; Chronic graft versus host disease; Hematopoietic stem cell transplantation

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOTRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; CASE REPORT; CHRONIC DISEASE; FATALITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; METHODOLOGY; ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER RECURRENCE; DEPRESSION; DRUG TOLERABILITY; INFECTION; LEUKOCYTE TRANSFUSION; PRIORITY JOURNAL; PUVA; SALVAGE THERAPY; STEM CELL MOBILIZATION; THROMBOCYTOPHERESIS;

ADULT; AUTOIMMUNE DISEASES; CHRONIC DISEASE; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; CASE REPORT; HUMAN;

ACICLOVIR; AZATHIOPRINE; CD34 ANTIGEN; CEFEPIME; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETRETIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; PREDNISONE; SERTRALINE; STEROID; SULFAMETHOXAZOLE; THYMOCYTE ANTIBODY; TRIMETHOPRIM;

EID: 0036015545     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703550     Document Type: Article

References (10)

1. Autologous hematopoietic stem cell transplants for autoimmune disease-feasibility and transplant-related mortality
2. High-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation for severe systemic sclerosis (SSc)
3. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation
4. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: Procedure related mortality and impact on skin disease
5. Cytokine expression in human cutaneous chronic graft-versus-host disease
6. Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: The University of Nebraska Experience
7. Chronic graft-versus-host disease
8. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease
9. Clinical course and predictive factors for cyclosporine-induced autologous graft-versus-host disease after autologous hematopoietic stem cell transplantation
10. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation